OptimizeRx Corp. (NASDAQ: OPRX) Stock Competitors & Peer Comparison
See OPRX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OPRX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OPRX | $6.66 | +2.30% | 125M | 6.11 | $1.09 | N/A |
| VEEV | $189.24 | -4.14% | 30.7B | 22.71 | $8.33 | N/A |
| GEHC | $62.04 | -1.26% | 28.2B | 13.61 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSGU | $239.04 | +3.24% | 14.4B | 216.59 | $1.11 | N/A |
| BTSG | $72.56 | +2.92% | 14.2B | 58.52 | $1.24 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| TEM | $48.98 | +1.18% | 8.5B | -97.96 | -$0.50 | N/A |
| HQY | $97.77 | -1.12% | 8.2B | 22.84 | $4.28 | N/A |
| HNGE | $84.35 | -3.82% | 6.5B | 43.22 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
OPRX vs VEEV Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, VEEV has a market cap of 30.7B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while VEEV trades at $189.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas VEEV's P/E ratio is 22.71. In terms of profitability, OPRX's ROE is +0.05%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, OPRX is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
OPRX vs GEHC Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while GEHC trades at $62.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas GEHC's P/E ratio is 13.61. In terms of profitability, OPRX's ROE is +0.05%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, OPRX is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
OPRX vs GEHCV Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas GEHCV's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, OPRX is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check GEHCV's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
OPRX vs BTSGU Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, BTSGU has a market cap of 14.4B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while BTSGU trades at $239.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas BTSGU's P/E ratio is 216.59. In terms of profitability, OPRX's ROE is +0.05%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, OPRX is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
OPRX vs BTSG Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, BTSG has a market cap of 14.2B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while BTSG trades at $72.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas BTSG's P/E ratio is 58.52. In terms of profitability, OPRX's ROE is +0.05%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, OPRX is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check BTSG's competition here
Signify Health, Inc. (NYSE: SGFY)
OPRX vs SGFY Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SGFY's P/E ratio is 70.91. In terms of profitability, OPRX's ROE is +0.05%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, OPRX is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check SGFY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
OPRX vs TEM Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, TEM has a market cap of 8.5B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while TEM trades at $48.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas TEM's P/E ratio is -97.96. In terms of profitability, OPRX's ROE is +0.05%, compared to TEM's ROE of -0.70%. Regarding short-term risk, OPRX is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check TEM's competition here
HealthEquity, Inc. (NASDAQ: HQY)
OPRX vs HQY Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, HQY has a market cap of 8.2B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while HQY trades at $97.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas HQY's P/E ratio is 22.84. In terms of profitability, OPRX's ROE is +0.05%, compared to HQY's ROE of +0.11%. Regarding short-term risk, OPRX is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
OPRX vs HNGE Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, HNGE has a market cap of 6.5B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while HNGE trades at $84.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas HNGE's P/E ratio is 43.22. In terms of profitability, OPRX's ROE is +0.05%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, OPRX is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
OPRX vs RCM Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas RCM's P/E ratio is -102.21. In terms of profitability, OPRX's ROE is +0.05%, compared to RCM's ROE of +0.00%. Regarding short-term risk, OPRX is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
OPRX vs TXG Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, TXG has a market cap of 6B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while TXG trades at $47.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas TXG's P/E ratio is -277.65. In terms of profitability, OPRX's ROE is +0.05%, compared to TXG's ROE of -0.03%. Regarding short-term risk, OPRX is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
OPRX vs DOCS Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, DOCS has a market cap of 3.9B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while DOCS trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas DOCS's P/E ratio is 13.79. In terms of profitability, OPRX's ROE is +0.05%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, OPRX is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
OPRX vs ONEM Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas ONEM's P/E ratio is -7.77. In terms of profitability, OPRX's ROE is +0.05%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, OPRX is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
OPRX vs PRVA Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, PRVA has a market cap of 3.3B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while PRVA trades at $26.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas PRVA's P/E ratio is 164.44. In terms of profitability, OPRX's ROE is +0.05%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, OPRX is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
OPRX vs PGNY Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while PGNY trades at $32.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas PGNY's P/E ratio is 23.53. In terms of profitability, OPRX's ROE is +0.05%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, OPRX is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
OPRX vs HTFL Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while HTFL trades at $25.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas HTFL's P/E ratio is -12.66. In terms of profitability, OPRX's ROE is +0.05%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, OPRX is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
OPRX vs WGS Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while WGS trades at $61.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas WGS's P/E ratio is 72.53. In terms of profitability, OPRX's ROE is +0.05%, compared to WGS's ROE of -0.28%. Regarding short-term risk, OPRX is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
OPRX vs TDOC Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, TDOC has a market cap of 1.8B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while TDOC trades at $9.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas TDOC's P/E ratio is -10.79. In terms of profitability, OPRX's ROE is +0.05%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, OPRX is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
OPRX vs NXGN Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas NXGN's P/E ratio is -266.00. In terms of profitability, OPRX's ROE is +0.05%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, OPRX is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check NXGN's competition here
Agiliti, Inc. (NYSE: AGTI)
OPRX vs AGTI Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas AGTI's P/E ratio is -71.79. In terms of profitability, OPRX's ROE is +0.05%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, OPRX is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
OPRX vs OMDA Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while OMDA trades at $22.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas OMDA's P/E ratio is 328.43. In terms of profitability, OPRX's ROE is +0.05%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, OPRX is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
OPRX vs CERT Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CERT trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CERT's P/E ratio is 17.56. In terms of profitability, OPRX's ROE is +0.05%, compared to CERT's ROE of -0.01%. Regarding short-term risk, OPRX is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
OPRX vs GDRX Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while GDRX trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas GDRX's P/E ratio is 9.15. In terms of profitability, OPRX's ROE is +0.05%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, OPRX is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
OPRX vs CCLDO Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CCLDO's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, OPRX is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
OPRX vs HSTM Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, HSTM has a market cap of 813.4M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while HSTM trades at $27.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas HSTM's P/E ratio is 36.63. In terms of profitability, OPRX's ROE is +0.05%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, OPRX is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check HSTM's competition here
Evolent Health, Inc. (NYSE: EVH)
OPRX vs EVH Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, EVH has a market cap of 656.9M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while EVH trades at $5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas EVH's P/E ratio is 584.00. In terms of profitability, OPRX's ROE is +0.05%, compared to EVH's ROE of -0.78%. Regarding short-term risk, OPRX is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check EVH's competition here
Phreesia, Inc. (NYSE: PHR)
OPRX vs PHR Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, PHR has a market cap of 654.6M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while PHR trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas PHR's P/E ratio is 37.82. In terms of profitability, OPRX's ROE is +0.05%, compared to PHR's ROE of +0.03%. Regarding short-term risk, OPRX is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
OPRX vs MPLN-WT Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, OPRX is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
OPRX vs ACCD Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas ACCD's P/E ratio is -3.08. In terms of profitability, OPRX's ROE is +0.05%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, OPRX is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
OPRX vs SHCR Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SHCR's P/E ratio is -3.76. In terms of profitability, OPRX's ROE is +0.05%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, OPRX is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
OPRX vs WGSWW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas WGSWW's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, OPRX is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check WGSWW's competition here
Claritev Corporation (NYSE: CTEV)
OPRX vs CTEV Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CTEV has a market cap of 488.4M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CTEV trades at $28.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CTEV's P/E ratio is -2.20. In terms of profitability, OPRX's ROE is +0.05%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, OPRX is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
OPRX vs NRC Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, NRC has a market cap of 484.1M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while NRC trades at $21.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas NRC's P/E ratio is 26.20. In terms of profitability, OPRX's ROE is +0.05%, compared to NRC's ROE of +0.57%. Regarding short-term risk, OPRX is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
OPRX vs SOPH Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SOPH has a market cap of 446.8M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SOPH trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SOPH's P/E ratio is -12.50. In terms of profitability, OPRX's ROE is +0.05%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, OPRX is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
OPRX vs SLGCW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, OPRX's ROE is +0.05%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, OPRX is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
OPRX vs SLGC Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SLGC's P/E ratio is -3.04. In terms of profitability, OPRX's ROE is +0.05%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, OPRX is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
OPRX vs TBRG Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas TBRG's P/E ratio is 9.37. In terms of profitability, OPRX's ROE is +0.05%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, OPRX is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
OPRX vs MPLN Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas MPLN's P/E ratio is -0.23. In terms of profitability, OPRX's ROE is +0.05%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, OPRX is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
OPRX vs SLP Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SLP's P/E ratio is 20.72. In terms of profitability, OPRX's ROE is +0.05%, compared to SLP's ROE of +0.06%. Regarding short-term risk, OPRX is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
OPRX vs TRHC Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas TRHC's P/E ratio is -4.27. In terms of profitability, OPRX's ROE is +0.05%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, OPRX is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
OPRX vs SMFR Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SMFR's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, OPRX is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check SMFR's competition here
So-Young International Inc. (NASDAQ: SY)
OPRX vs SY Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SY has a market cap of 240.1M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SY trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SY's P/E ratio is -5.55. In terms of profitability, OPRX's ROE is +0.05%, compared to SY's ROE of -0.16%. Regarding short-term risk, OPRX is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check SY's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
OPRX vs SPOK Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SPOK has a market cap of 222.7M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SPOK trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SPOK's P/E ratio is 17.77. In terms of profitability, OPRX's ROE is +0.05%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, OPRX is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
OPRX vs AMWL Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, AMWL has a market cap of 209M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while AMWL trades at $12.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas AMWL's P/E ratio is -2.41. In terms of profitability, OPRX's ROE is +0.05%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, OPRX is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
OPRX vs HCAT Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, HCAT has a market cap of 159.6M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while HCAT trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas HCAT's P/E ratio is 10.80. In terms of profitability, OPRX's ROE is +0.05%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, OPRX is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
OPRX vs CPSI Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CPSI's P/E ratio is -183.80. In terms of profitability, OPRX's ROE is +0.05%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, OPRX is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check CPSI's competition here
Augmedix, Inc. (NASDAQ: AUGX)
OPRX vs AUGX Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas AUGX's P/E ratio is -4.99. In terms of profitability, OPRX's ROE is +0.05%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, OPRX is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
OPRX vs CCLD Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CCLD has a market cap of 94.8M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CCLD trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CCLD's P/E ratio is 8.26. In terms of profitability, OPRX's ROE is +0.05%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, OPRX is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
OPRX vs DH Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, DH has a market cap of 76.5M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while DH trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas DH's P/E ratio is 2.79. In terms of profitability, OPRX's ROE is +0.05%, compared to DH's ROE of -0.67%. Regarding short-term risk, OPRX is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
OPRX vs FORA Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas FORA's P/E ratio is -24.11. In terms of profitability, OPRX's ROE is +0.05%, compared to FORA's ROE of -0.17%. Regarding short-term risk, OPRX is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
OPRX vs CCLDP Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CCLDP's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, OPRX is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
OPRX vs ONMD Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, ONMD has a market cap of 37.2M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while ONMD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas ONMD's P/E ratio is -4.36. In terms of profitability, OPRX's ROE is +0.05%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, OPRX is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
OPRX vs SNCE Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SNCE's P/E ratio is -0.27. In terms of profitability, OPRX's ROE is +0.05%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, OPRX is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
OPRX vs AKLI Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas AKLI's P/E ratio is -0.71. In terms of profitability, OPRX's ROE is +0.05%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, OPRX is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
OPRX vs SHLT Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SHLT's P/E ratio is -3.87. In terms of profitability, OPRX's ROE is +0.05%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, OPRX is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
OPRX vs ONMDW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, ONMDW has a market cap of 33.2M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas ONMDW's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, OPRX is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check ONMDW's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
OPRX vs SHCRW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, OPRX's ROE is +0.05%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, OPRX is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
OPRX vs EUDA Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, EUDA has a market cap of 26.8M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while EUDA trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas EUDA's P/E ratio is -27.08. In terms of profitability, OPRX's ROE is +0.05%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, OPRX is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check EUDA's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
OPRX vs STRM Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas STRM's P/E ratio is -2.40. In terms of profitability, OPRX's ROE is +0.05%, compared to STRM's ROE of -0.32%. Regarding short-term risk, OPRX is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
OPRX vs RNLX Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas RNLX's P/E ratio is -0.33. In terms of profitability, OPRX's ROE is +0.05%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, OPRX is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
OPRX vs LIFW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas LIFW's P/E ratio is -0.02. In terms of profitability, OPRX's ROE is +0.05%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, OPRX is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
OPRX vs BEATW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, BEATW has a market cap of 18M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas BEATW's P/E ratio is -0.05. In terms of profitability, OPRX's ROE is +0.05%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, OPRX is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
OPRX vs BBLN Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas BBLN's P/E ratio is -0.04. In terms of profitability, OPRX's ROE is +0.05%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, OPRX is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
OPRX vs ETAO Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas ETAO's P/E ratio is -0.01. In terms of profitability, OPRX's ROE is +0.05%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, OPRX is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
OPRX vs BFRG Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while BFRG trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas BFRG's P/E ratio is -1.19. In terms of profitability, OPRX's ROE is +0.05%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, OPRX is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
OPRX vs SCNX Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas SCNX's P/E ratio is -0.15. In terms of profitability, OPRX's ROE is +0.05%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, OPRX is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
OPRX vs UPH Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas UPH's P/E ratio is -0.07. In terms of profitability, OPRX's ROE is +0.05%, compared to UPH's ROE of -1.05%. Regarding short-term risk, OPRX is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
OPRX vs UPH-WT Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, OPRX is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
OPRX vs MGRX Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, MGRX has a market cap of 4.8M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while MGRX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas MGRX's P/E ratio is -0.35. In terms of profitability, OPRX's ROE is +0.05%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, OPRX is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
OPRX vs PEAR Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas PEAR's P/E ratio is -0.08. In terms of profitability, OPRX's ROE is +0.05%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, OPRX is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
OPRX vs PEARW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas PEARW's P/E ratio is -0.00. In terms of profitability, OPRX's ROE is +0.05%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, OPRX is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
OPRX vs OTRK Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas OTRK's P/E ratio is -0.02. In terms of profitability, OPRX's ROE is +0.05%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, OPRX is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
OPRX vs HCTI Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while HCTI trades at $1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas HCTI's P/E ratio is -0.22. In terms of profitability, OPRX's ROE is +0.05%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, OPRX is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
OPRX vs CMAX Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CMAX's P/E ratio is -0.00. In terms of profitability, OPRX's ROE is +0.05%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, OPRX is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
OPRX vs VSEE Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, VSEE has a market cap of 1.5M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while VSEE trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas VSEE's P/E ratio is -0.17. In terms of profitability, OPRX's ROE is +0.05%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, OPRX is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
OPRX vs ACON Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while ACON trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas ACON's P/E ratio is -0.24. In terms of profitability, OPRX's ROE is +0.05%, compared to ACON's ROE of -0.54%. Regarding short-term risk, OPRX is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
OPRX vs LIFWZ Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, OPRX is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
OPRX vs VSEEW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, VSEEW has a market cap of 1.2M. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, OPRX's ROE is +0.05%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, OPRX is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check VSEEW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
OPRX vs EUDAW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, OPRX's ROE is +0.05%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, OPRX is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
OPRX vs WORX Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, WORX has a market cap of 602.8K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while WORX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas WORX's P/E ratio is -0.66. In terms of profitability, OPRX's ROE is +0.05%, compared to WORX's ROE of -0.65%. Regarding short-term risk, OPRX is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
OPRX vs MSPRZ Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, OPRX is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
OPRX vs KERN Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas KERN's P/E ratio is -0.01. In terms of profitability, OPRX's ROE is +0.05%, compared to KERN's ROE of -0.17%. Regarding short-term risk, OPRX is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
OPRX vs KERNW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas KERNW's P/E ratio is -0.00. In terms of profitability, OPRX's ROE is +0.05%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, OPRX is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
OPRX vs LIFWW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas LIFWW's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, OPRX is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
OPRX vs ZCMD Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, ZCMD has a market cap of 51.1K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while ZCMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, OPRX's ROE is +0.05%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, OPRX is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
OPRX vs CMAXW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CMAXW's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, OPRX is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
OPRX vs ACONW Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, ACONW has a market cap of 11.2K. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas ACONW's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, OPRX is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
OPRX vs MTBCO Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas MTBCO's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, OPRX is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check MTBCO's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
OPRX vs AFFX Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas AFFX's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, OPRX is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
OPRX vs MTBCP Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas MTBCP's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, OPRX is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
OPRX vs MTBC Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas MTBC's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, OPRX is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
OPRX vs CHNG Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CHNG's P/E ratio is -152.72. In terms of profitability, OPRX's ROE is +0.05%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, OPRX is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
OPRX vs CHNGU Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CHNGU's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, OPRX is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CHNGU's competition here
Cue Health Inc. (NASDAQ: HLTH)
OPRX vs HLTH Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, HLTH has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while HLTH trades at $25.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas HLTH's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, OPRX is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check HLTH's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
OPRX vs CNVY Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CNVY's P/E ratio is -71.50. In terms of profitability, OPRX's ROE is +0.05%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, OPRX is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
OPRX vs NAVA Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas NAVA's P/E ratio is N/A. In terms of profitability, OPRX's ROE is +0.05%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, OPRX is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for OPRX.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
OPRX vs CERN Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CERN has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CERN's P/E ratio is 55.84. In terms of profitability, OPRX's ROE is +0.05%, compared to CERN's ROE of +0.14%. Regarding short-term risk, OPRX is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
OPRX vs CSLT Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas CSLT's P/E ratio is -37.27. In terms of profitability, OPRX's ROE is +0.05%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, OPRX is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for OPRX.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
OPRX vs NH Comparison July 2026
OptimizeRx Corp. (NASDAQ: OPRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPRX stands at 125M. In comparison, NH has a market cap of 0. Regarding current trading prices, OPRX is priced at $6.66 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPRX currently has a P/E ratio of 6.11, whereas NH's P/E ratio is -0.12. In terms of profitability, OPRX's ROE is +0.05%, compared to NH's ROE of +0.35%. Regarding short-term risk, OPRX is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for OPRX.Check NH's competition here